Skip to content

Observational prospective study of treatment for delirium

Observational prospective study of treatment for delirium - Observational prospective study of treatment for delirium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010465
Enrollment
280
Registered
2013-04-11
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with delirium

Interventions

None listed

Sponsors

Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.inpatients 2.delirious patients who treated with single drug

Exclusion criteria

Exclusion criteria: 1.demented patients 2.alcohol withdrawal delirium 3.terminal delirium 4.aphasiac 5.in case of formulation change 6.in case of judging as exclusion by attending doctor

Design outcomes

Primary

MeasureTime frame
The association between the improvement factors of MDAS total/sub-score and drugs used for treatment of delirium

Secondary

MeasureTime frame
The association between the improvement factors of MDAS sub-score and pharmacological profiles of drugs used for treatment of delirium

Countries

Japan

Contacts

Public ContactHitoshi Tanimukai

Osaka University Graduate School of Medicine Department of Psychiatry

tanimuki@psy.med.osaka-u.ac.jp06-6879-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026